Legend Biotech (LEGN) Current Taxes (2020 - 2026)

Legend Biotech (LEGN) has 7 years of Current Taxes data on file, last reported at $20.3 million in Q1 2026.

• Quarterly Current Taxes rose 44.91% year-over-year to $20.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $20.3 million (up 44.91% YoY) and the FY2025 annual result came in at $19.2 million, down 7.25% from the prior year.
• Current Taxes grew to $20.3 million in Q1 2026, from $19.2 million in the prior quarter.
• In the past five years, Current Taxes ranged from a high of $20.7 million in Q4 2024 to a low of $6.6 million in Q2 2024.
• A 5-year average of $11.8 million and a median of $10.1 million in 2025 frame the typical range for Current Taxes.
• The widest YoY moves for Current Taxes: up 187.38% in 2024, down 36.41% in 2024.
• Tracing LEGN's Current Taxes over 5 years: stood at $9.8 million in 2022, then fell by 26.29% to $7.2 million in 2023, then surged by 187.38% to $20.7 million in 2024, then declined by 7.25% to $19.2 million in 2025, then grew by 5.73% to $20.3 million in 2026.
• The last three Current Taxes figures came in at $20.3 million (Q1 2026), $19.2 million (Q4 2025), and $10.1 million (Q3 2025), per Business Quant data.